ADA and endothelial dysfunction: Experiments with exogenous 4PYR administration showed that higher 4PYR was linked to enhanced lung metastasis, in which endothelial dysfunction could be mechanistically involved, as indicated by impaired NAD metabolism, an increased activity of vascular ecto-adenosine deaminase, and impaired L-arginine metabolism.